Extendicare Company Executives
| EXE Stock | CAD 22.54 0.26 1.17% |
Extendicare employs about 31 people. The company is managed by 31 executives with a total tenure of roughly 114 years, averaging almost 3.0 years of service per executive, having 1.0 employees per reported executive. Analysis of Extendicare's management performance can provide insight into the firm performance.
| Michael Guerriere CEO President, Chief Executive Officer, Director |
| Alan Torrie Chairman Independent Chairman of the Board |
Extendicare |
Extendicare Management Team Effectiveness
The company has return on total asset (ROA) of 0.104 % which means that it generated a profit of $0.104 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.6557 %, meaning that it generated $0.6557 on every $100 dollars invested by stockholders. Extendicare's management efficiency ratios could be used to measure how well Extendicare manages its routine affairs as well as how well it operates its assets and liabilities. As of the 17th of January 2026, Return On Tangible Assets is likely to grow to 0.12. Also, Return On Capital Employed is likely to grow to 0.31. At this time, Extendicare's Fixed Asset Turnover is very stable compared to the past year. As of the 17th of January 2026, Return On Assets is likely to grow to 0.1, while Non Current Assets Total are likely to drop about 407.1 M.As of the 17th of January 2026, Common Stock Shares Outstanding is likely to drop to about 92.7 M. In addition to that, Net Income Applicable To Common Shares is likely to drop to about 51.4 MExtendicare holds a total of 94.46 Million outstanding shares. 30% of Extendicare outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Shares in Circulation | First Issued 2003-03-31 | Previous Quarter 85.6 M | Current Value 85.8 M | Avarage Shares Outstanding 86.5 M | Quarterly Volatility 13.7 M |
Extendicare Workforce Comparison
Extendicare is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 15,424. Extendicare adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Extendicare Profit Margins
The company has Profit Margin (PM) of 0.06 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.09 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.09.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.13 | 0.1146 |
|
| |||||
| Operating Profit Margin | 0.0769 | 0.0872 |
|
|
Extendicare Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Extendicare Price Series Summation is a cross summation of Extendicare price series and its benchmark/peer.
Extendicare Notable Stakeholders
An Extendicare stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Extendicare often face trade-offs trying to please all of them. Extendicare's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Extendicare's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| MBA MD | President CEO | Profile | |
| Michael Guerriere | President, Chief Executive Officer, Director | Profile | |
| Alan Torrie | Independent Chairman of the Board | Profile | |
| Jillian Fountain | Vice President - Investor Relations | Profile | |
| Elaine Everson | Vice President - Corporate Development | Profile | |
| David Bacon | Chief Financial Officer, Senior Vice President | Profile | |
| David CPA | Executive CFO | Profile | |
| Steve Paraskevopoulos | Senior CTO | Profile | |
| Samir Manji | Independent Director | Profile | |
| Sandra Hanington | Independent Director | Profile | |
| Alan Hibben | Independent Director | Profile | |
| Donna Kingelin | Independent Director | Profile | |
| Norma Beauchamp | Independent Director | Profile | |
| Aladin Mawani | Independent Director | Profile | |
| Katarina Busija | Chief VP | Profile | |
| Joe Belinsky | VP Officer | Profile | |
| Jillian CPA | Vice Relations | Profile | |
| Ali Mir | Vice President - ParaMed Operations | Profile | |
| Brent Houlden | Independent Director | Profile | |
| Kathryn Bradley | Vice Development | Profile | |
| Amie Vahrmeyer | Vice ON | Profile | |
| Liselie Sarauer | Chief Human Resource Officer, Senior Vice President | Profile | |
| Katie LeMoyne | Senior Officer | Profile | |
| Bruce Wienberg | VP Care | Profile | |
| Danielle Parr | Vice Affairs | Profile | |
| Wendy Gilmour | Senior Operations | Profile | |
| Lisa Pearson | VP Affairs | Profile | |
| Matthew Morgan | Chief Officer | Profile | |
| Leslie Sarauer | VP Officer | Profile | |
| Mark Trenholm | Senior Finance | Profile | |
| John Toffoletto | Senior Vice President Chief Legal Officer and Corporate Secretary | Profile |
About Extendicare Management Performance
The success or failure of an entity such as Extendicare often depends on how effective the management is. Extendicare management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Extendicare management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Extendicare management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.11 | 0.12 | |
| Return On Capital Employed | 0.30 | 0.31 | |
| Return On Assets | 0.09 | 0.10 | |
| Return On Equity | 0.54 | 0.57 |
Extendicare Workforce Analysis
Traditionally, organizations such as Extendicare use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Extendicare within its industry.Extendicare Manpower Efficiency
Return on Extendicare Manpower
| Revenue Per Employee | 47.3M | |
| Revenue Per Executive | 47.3M | |
| Net Income Per Employee | 2.4M | |
| Net Income Per Executive | 2.4M |
Other Information on Investing in Extendicare Stock
Extendicare financial ratios help investors to determine whether Extendicare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.